Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1097)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$486.32
Total Value
$77.81K
Shares Held After
333,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$485.12
Total Value
$58.21K
Shares Held After
333,303
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$482.61
Total Value
$38.61K
Shares Held After
333,423
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$479.89
Total Value
$76.78K
Shares Held After
333,503
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$478.85
Total Value
$76.62K
Shares Held After
333,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$477.70
Total Value
$57.32K
Shares Held After
333,823
% of Holdings
0.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
900
Price
$68.95
Total Value
$62.05K
Shares Held After
526,900
% of Holdings
0.2%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
642
Price
$66.37
Total Value
$42.61K
Shares Held After
118,016
% of Holdings
0.5%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
400
Price
$26.64
Total Value
$10.65K
Shares Held After
9,110
% of Holdings
4.2%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
5,387
Price
$25.69
Total Value
$138.42K
Shares Held After
9,510
% of Holdings
36.2%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
187,704
Price
$1.80
Total Value
$337.59K
Shares Held After
5,624,151
% of Holdings
3.3%
AN2 Therapeutics, Inc. (ANTX)
Williams Sarah Joanne — Principal Accounting Officer
Shares
272
Price
$5.53
Total Value
$1.50K
Shares Held After
66,311
% of Holdings
0.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
4,601
Price
$73.86
Total Value
$339.83K
Shares Held After
18,707
% of Holdings
19.7%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
31,908
Price
$26.29
Total Value
$838.78K
Shares Held After
223,355
% of Holdings
12.5%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,593
Price
$26.31
Total Value
$68.21K
Shares Held After
18,151
% of Holdings
12.5%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
1
Price
$79.95
Total Value
$79.95
Shares Held After
14,012
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
58
Price
$79.95
Total Value
$4.64K
Shares Held After
337,427
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
70
Price
$79.95
Total Value
$5.60K
Shares Held After
349,140
% of Holdings
0.0%
VERACYTE, INC. (VCYT)
Bhanji Muna — Director
Shares
1,864
Price
$42.97
Total Value
$80.10K
Shares Held After
42,718
% of Holdings
4.2%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
400
Price
$89.38
Total Value
$35.75K
Shares Held After
2,845
% of Holdings
12.3%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
6,206
Price
$88.17
Total Value
$547.18K
Shares Held After
3,245
% of Holdings
65.7%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
16,548
Price
$87.20
Total Value
$1.44M
Shares Held After
9,451
% of Holdings
63.6%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — See Remarks
Shares
4,845
Price
$86.40
Total Value
$418.61K
Shares Held After
25,999
% of Holdings
15.7%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
2,281
Price
$115.61
Total Value
$263.71K
Shares Held After
9,755
% of Holdings
19.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
10,989
Price
$114.71
Total Value
$1.26M
Shares Held After
12,036
% of Holdings
47.7%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
11,730
Price
$113.94
Total Value
$1.34M
Shares Held After
23,025
% of Holdings
33.8%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
200
Price
$89.04
Total Value
$17.81K
Shares Held After
97,994
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
400
Price
$89.07
Total Value
$35.63K
Shares Held After
552,540
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,016
Price
$88.03
Total Value
$177.47K
Shares Held After
98,194
% of Holdings
2.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,700
Price
$88.06
Total Value
$325.82K
Shares Held After
552,940
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
4,384
Price
$87.11
Total Value
$381.89K
Shares Held After
100,210
% of Holdings
4.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
8,400
Price
$87.15
Total Value
$732.06K
Shares Held After
556,640
% of Holdings
1.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
900
Price
$86.25
Total Value
$77.62K
Shares Held After
104,594
% of Holdings
0.9%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,500
Price
$86.36
Total Value
$215.90K
Shares Held After
565,040
% of Holdings
0.4%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
29,088
Price
$7.06
Total Value
$205.36K
Shares Held After
4,202,346
% of Holdings
0.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
29,088
Price
$7.06
Total Value
$205.36K
Shares Held After
4,202,346
% of Holdings
0.7%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
584
Price
$14.00
Total Value
$8.18K
Shares Held After
8,617
% of Holdings
6.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
21,688
Price
$98.91
Total Value
$2.15M
Shares Held After
194,440
% of Holdings
10.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
8,312
Price
$98.08
Total Value
$815.24K
Shares Held After
216,128
% of Holdings
3.7%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
3,333
Price
$37.83
Total Value
$126.08K
Shares Held After
96,412
% of Holdings
3.3%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
132
Price
$355.86
Total Value
$46.97K
Shares Held After
0
% of Holdings
100.0%
Moderna, Inc. (MRNA)
Klinger Shannon Thyme — Chief Legal Officer
Shares
3,471
Price
$139.95
Total Value
$485.77K
Shares Held After
74,129
% of Holdings
4.5%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,141
Price
$26.36
Total Value
$425.51K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
13,309
Price
$106.74
Total Value
$1.42M
Shares Held After
4,000
% of Holdings
76.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
7,215
Price
$106.25
Total Value
$766.59K
Shares Held After
17,309
% of Holdings
29.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
2,600
Price
$105.19
Total Value
$273.49K
Shares Held After
24,524
% of Holdings
9.6%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
274
Price
$67.76
Total Value
$18.57K
Shares Held After
117,308
% of Holdings
0.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,600
Price
$31.06
Total Value
$49.69K
Shares Held After
20,110
% of Holdings
7.4%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
3,945
Price
$30.51
Total Value
$120.37K
Shares Held After
21,710
% of Holdings
15.4%
Denali Therapeutics Inc. (DNLI)
Schuth Alexander O. — COFO and Secretary
Shares
2,768
Price
$23.44
Total Value
$64.88K
Shares Held After
278,995
% of Holdings
1.0%
Showing 151–200 of 1097 transactions (page 4 of 22)